Study | Country Study period Study design |
Data source | Exposure definition | Non-exposure definition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|---|---|---|---|---|---|---|---|
Mabie 1986 |
USA 1980 - 1984 prospective cohort |
The Tulane Obstetrical Service of Charity Hospital at New Orleans, Louisiana, USA. | Pregnant women with chronic hypertension treated with Hydrochlorothiazide only. |
unexposed, sick
Pregnant women with chronic hypertension without treatment. |
during pregnancy (anytime or not specified) | 10 / 82 | Data on Hydrochlorothiazide only reported rather than co-administration Methyldopa and hydrochlorothiazide. | |
Not specified (study conducted in a department of obstetrics and gynecology but the source of exposure data, not clearly specified). |
Study | Country Study period Study design |
Data source | Case | Control | Exposition | Exposition period | Sample size (exposed/unexposed) Or (case / control) |
Remarks | Risk of bias |
---|---|---|---|---|---|---|---|---|---|
Medveczky 2004 |
Hungary 1980 - 1996 case control |
The Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). | Newborn infants (including infant deaths and usual stillborn fetuses) with Neural tube defects with non-syndromic (i.e. isolated anencephaly, spina bifida aperta/cystica, encephalocele). | Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities. | Exposure data collected from 3 sources: a post-paid structured questionnaire sent to the parents requesting drugs taken during pregnancy, according to gestational months; maternal prenatal care logbook (in which obstetricians must record all prescribed drugs); nurses visited non-responding families. | 1st trimester | 1202 / 38151 | Study design completed with other studies published on the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). | |
The Hungarian Congenital Abnormality Registry (HCAR), in which notification by physicians of cases with Congenital anomalies is mandatory (including infant deaths and usual stillborn fetuses). Controls were selected from the National Birth Registry of the Central Statistical Office. | |||||||||
Van Zutphen 2014 |
USA 1997 - 2009 case control |
The National Birth Defects Prevention Study, USA. | All cases (liveborn, stillborn after 20 weeks gestation, or induced abortions) with severe hypospadias (ie, subcoronal or penile, scrotal, or perineal meatal opening) diagnosed at the time of physical examination, surgery, or autopsy. | Male live births without birth defects randomly selected from birth certificates or hospital discharge listings in the same population as the case neonates. | Antihypertensive medication use were collected by trained interviewers who conducted maternal telephone interviews within 24 months of delivery. | early pregnancy | 2131 / 5129 | Mothers reporting antihypertensive medications for the treatment of other indications (eg, b-blockers for migraine headaches) were excluded from the analyses. | |
Data were abstracted from medical record, birth certificates or hospital discharge records. To confirm cases, clinical geneticists reviewed data, including consultations (urology, endocrinology, and genetic), reports (operative, pathology, and autopsy), and radiographic results. | |||||||||
Vermes 2015 |
Hungary 1980 - 1996 case control |
The Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). | Newborn infants (including infant deaths and usual stillborn fetuses) with isolated Oesophageal Atresia. | Newborn infants (including infant deaths and usual stillborn fetuses) without congenital abnormalities. | Exposure data collected from 3 sources: a post-paid structured questionnaire sent to the parents requesting drugs taken during pregnancy, according to gestational months; maternal prenatal care logbook (in which obstetricians must record all prescribed drugs); nurses visited non-responding families. | 1st trimester, during pregnancy (anytime or not specified) | 221 / 356 | Study design completed with other studies published on the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA). Cases with multiple/syndromic Oesophageal Atresia were excluded from the study. | |
The Hungarian Congenital Abnormality Registry (HCAR), in which notification by physicians of cases with Congenital anomalies is mandatory (including infant deaths and usual stillborn fetuses). Controls were selected from the National Birth Registry of the Central Statistical Office. |
Risk of bias: : NA; : low; : moderate; : serious; : critical; : unclear;